ContractCollaboration and License Agreement • February 10th, 2025 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 10th, 2025 Company Industry Jurisdiction
COLLABORATION AND LICENSE AGREEMENT By and between VOYAGER THERAPEUTICS, INC. AND NEUROCRINE BIOSCIENCES, INC.Collaboration and License Agreement • February 8th, 2019 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 8th, 2019 Company Industry JurisdictionThis COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 28, 2019 (the “Execution Date”), by and between Voyager Therapeutics, Inc., a Delaware corporation, having its principal place of business at 75 Sidney Street, Cambridge, MA 02139 (“Voyager”), and Neurocrine Biosciences, Inc., a Delaware corporation, having its principal place of business at 12780 El Camino Real, San Diego, CA 92130 (“Neurocrine”). Voyager and Neurocrine shall be referred to herein individually as a “Party” and collectively as the “Parties”.